HEPS_UGANDA

WEEKLY HEALTH NEWS HIGHLIGHTS

Airline passengers arriving in the US from Uganda will be routed through five airports for Ebola screening

WEEKLY HEALTH NEWS HIGHLIGHTS

Organizations launch campaign to fight tetanus

WEEKLY HEALTH NEWS HIGHLIGHTS

HEPS and partners launch the Stop Tetanus Campaign

WEEKLY HEALTH NEWS HIGHLIGHTS

China approves inhaled Covid vaccine

A PATENT WAIVER THAT NEVER WAS: WHERE DO WE GO FROM HERE?

POLICY BRIEF, JULY 2022

After nearly two years of intense negotiations, member states of the World
Trade Organization (WTO) has finally agreed on a deal that waives patents and
other intellectual property rights (IPRs) on Covid-19 vaccines. However, the
highly restrictive deal – “at best, a distant cousin of the original proposal”1
that sought a full waiver of protections on patents, trade secrets, copyrights
and industrial designs on not only vaccines but also on diagnostics and
therapeutics – is unlikely to boost global vaccine production and equity. This
brief argues that while Low- and Middle-Income Countries (LMICs) should
endeavor to utilize the WTO’s tokenish waiver, the campaign continues for
a meaningful pathway to global equity in access to COVID-19 vaccines and
other pandemic response tools.

WEEKLY HEALTH NEWS HIGHLIGHTS

Global COVID-19 cases surpass 600 mln: WHO

WEEKLY HEALTH NEWS HIGHLIGHTS

WHO experts back second Covid booster for most at risk<

WEEKLY HEALTH NEWS HIGHLIGHTS

Experts Call for Increase Heath Sector Financing

WEEKLY HEALTH NEWS HIGHLIGHTS

Court exonerates health workers

WEEKLY HEALTH NEWS HIGHLIGHTS

Protests as ARV drugs shortage hits Uganda